Announced Mon, 6 Jul · 17:57 IST
Routine quarterly compliance certificate filed with exchanges for Q1 FY27
Compliance View source PDF
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-5.7%1-day move
₹1255.00
prior close
₹1256.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.8-0.9—-5.7-1.3+5.3+10.8+12.4+13.1————
Up moveDown movePending
AI summary
Tatva Chintan Pharma Chem has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The certificate was issued by MUFG Intime India, the company's Registrar and Share Transfer Agent, confirming that all securities received for dematerialisation during the quarter were properly processed. Share certificates were mutilated and cancelled, and the depositories' names were recorded as registered owners within the required timelines.
Likely market impact
No material impact. This is a routine quarterly regulatory compliance filing required of all listed companies.